News & Press

Redbiotec and TeselaGen to Partner on Herpesvirus vaccine library

Redbiotec and TeselaGen have announced a joint venture to build a scalable, integrated, rapid design and rapid prototyping infrastructure for the creation of a library for Herpesvirus vaccine development. This library will enable new concepts for vaccines against Herpesviruses and will enable the optimization and improvement of new and existing vaccine candidates.

Read More

Genomatica Licenses TeselaGen Software For DNA Design

Genomatica and TeselaGen have signed a multi-year agreement to license TeselaGen’s software, which uses synthetic biology approaches to build and modify DNA. The two companies also will work together to enhance TeselaGen’s software to meet Genomatica’s objectives.

By using TeselaGen’s technology, Genomatica expects to accelerate development of its proprietary organisms. These organisms are an important part of the overall process technology that Genomatica delivers to its licensees for the production of major chemicals from renewable feedstocks. TeselaGen’s software provides an advanced biological computer aided design and manufacture system, with automated DNA design and assembly protocol generation.

Read More

TeselaGen Wins A Second NSF SBIR Award

TeselaGen Biotechnology has secured a second National Science Foundation Small Business Innovation and Research grant to pursue “Directed DNA Synthesis and Assembly”. The grant is focused on the “Build” aspect of TeselaGen’s four-step approach to software for synthetic biology, encompassing a “Design, Build, Test, and Evolve” methodology.

Read More

How To Code A Life

TeselaGen featured in article detailing how new synthetic biology tools are accelerating genetic engineering.

Read More

TeselaGen To Accelerate Biotech Industry With J5

TeselaGen has secured an exclusive license in all fields of use for the “j5” gene assembly software from Lawrence Berkeley National Laboratory . TeselaGen prevailed with the strongest proposal to promote and leverage the j5 technology for their rapid prototyping system for synthetic biology. Based on the idea that a forward engineering approach needs to incorporate the utility of both biology and engineering in the quest for easier and faster ways to build biomolecules, TeselaGen is expecting the j5 technology to play an important role in its software as a service offering. The j5 software package, which has attracted users from more than 250 institutions worldwide since it was made available last year, emerged from the Joint BioEnergy Institute, a Department of Energy research center established in 2007 to pursue breakthroughs in the production of cellulosic biofuels. By building on j5 and adding modules for commercial users, TeselaGen Biotechnology, says it will significantly reduce the time and cost involved with DNA synthesis and cloning, a multibillion-dollar market.

Read More

TeselaGen Wins NSF SBIR Award

TeselaGen Biotechnology has secured a National Science Foundation Small Business Innovation and Research grant to pursue “A Synthetic Biology Design-Build-Test Platform for Automated Combinatorial DNA Assembly”. The grant focuses on the first part of TeselaGen’s Design, Build, Test, Evolve approach to biomolecule design. According to TeselaGen CEO Michael Fero “We decided to put the design principles of Synthetic Biology to the test, building our software framework along lines that model the forward engineering approach, while not ignoring the special ability of biological systems to design themselves through evolutionary mechanisms”

Read More